IDO1 and type 1 diabetes mellitus: This study aimed to assess the effects of EndTr, NLE, and their combination on the IDO1-KYN-AHR pathway in the liver of rats with STZ-induced diabetes while taking into account the increasing incidence of T1D worldwide (42).